Field of Vision
Copyright ©The Author(s) 2016.
World J Transplant. Jun 24, 2016; 6(2): 255-271
Published online Jun 24, 2016. doi: 10.5500/wjt.v6.i2.255
Table 7 Portal-enteric drainage: Literature review
Center, authors, year, ref., study design and follow-upNumber and type of transplantComplicationsReadmissions, reoperation, length of stay1 yr patient survival1 yr kidney and pancreas graft survival
University of Tennessee, Stratta et al[122], Retrospective, mean follow-up 3 yrPE 126; 90 SPK; 18 PAK; 18 PTA; Era 1 (10/90-6/95); Era 2 (7/95-5/98); Era 3 (6/98-12/99)In 3 successive eras, rates of acute rejection were 63%, 33%, and 39%, respectively; rates of major infection were 60%, 43%, and 44%, respectivelyIn 3 successive eras, rates of relaparotomy were 47%, 31%, and 33%, respectively; rates of thrombosis were 20%, 7%, and 6%, respectively. Mean length of stay: 12.5 dIn 3 successive eras, patient survival was 77%, 93%, and 100%, respectivelyIn 3 successive eras, kidney graft survival was 77%, 93%, and 94%, respectively; pancreas graft survival was 60%, 83%, and 83%, respectively
Università di Pisa, Italy, Boggi et al[17], Retrospective, mean follow-up 21 ± 20 moPE 11010 grafts were lost; 3 acute rejection, 2 chronic rejection, 2 venous thrombosis, 2 deaths, 1 late thrombosis (6 mo). Incidence of pancreas acute rejection was 6%Relaparotomy rate was 13.6%; Mean length of stay was 26 ± 14 d; One month readmission rate was 13%98%Pancreas graft survival was 91%
University of Chicago, Bruce et al[116], Retrospective, mean follow-up 16 moPE 70Pancreas graft losses: Thrombosis (3), acute rejection (5), late duodenal perforation (2)Total 1st year hospitalization: 37 ± 28 d; Relaparotomy in 14 (70%)88%Kidney 78%; Pancreas 79%
Louisiana State University, Zibari et al[23], Retrospective, mean follow-up 25 moPE 21Postoperative Bleeding in 4, wound infections in 4, acute rejection in 9, pancreas graft loss in 2Mean length of stay was 16 d100%Kidney 90%; Pancreas 90%
Wake Forest Baptist Medical Center, Rogers et al[4], Retrospective, mean follow-up 6 ± 3 yr202; SPK 162, PAK 35, PTA 5; PE 179; SE 23Thrombosis rate was 8%; acute rejection rate was 28%; major infection rate was 50%Mean length of stay was 13 d; Relaparotomy rate was 38%Overall patient survival was 87%; one-year patient survival was 97%Overall kidney and pancreas graft survival rates are 76% and 65%; death-censored graft survival rates are 84% and 72%, and one year graft survival rates are 94% and 88%, respectively
Monash Medical Centre, Victoria, Australia, Kave et al[118], Retrospective, mean follow-up 2 yrSB 37; PE 27Pancreas graft thrombosis rates SB 10.8%, PE 7.4% (P = NS)Two-year patient survival was SB 94.3% vs PE 96.0%Two year kidney (SB 89.2% vs PE 85.2%); pancreas (SB 77.9% vs PE 71.4%)